Eli Lilly Stock Soars While Novo Nordisk Sinks—Why the Weight-Loss Leaders Are Headed in Opposite Directions - Investopedia
Eli Lilly's stock surged Wednesday while shares of weight-loss rival Novo Nordisk slumped, widening the gap between the drugmakers.
:max_bytes(150000):strip_icc()/Novo-lilly-055e6cc622fc4aa59279cd13e672bb7c.png)
Comments